STOCK TITAN

SAIC closes $500M senior notes offering due 2034

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Science Applications International Corp. (SAIC) closed a private offering of $500 million aggregate principal amount of 6.750% Senior Notes due 2034. The company received approximately $493 million in net proceeds after the initial purchasers’ discount and estimated fees and expenses. It used proceeds to redeem all outstanding 4.875% Senior Notes due 2028; it intends to pay the new offering’s estimated fees and expenses, with any remaining net proceeds for general corporate purposes.

The new notes are senior unsecured obligations, guaranteed by existing and future domestic subsidiaries that guarantee obligations under the company’s credit agreement and certain other indebtedness. Before December 1, 2029, SAIC may redeem notes at 100% of principal plus accrued interest and a make-whole premium; on or after that date, redemption prices set in the notes apply. Through December 1, 2029, it may redeem up to 40% of original principal at 106.750% using proceeds from certain equity offerings. A change of control may require an offer to repurchase notes at 101% of principal plus accrued interest. The indenture also limits certain liens, sale-and-leaseback transactions, and consolidation, mergers or sales of substantially all assets.

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Aggregate principal amount $500 million 6.750% Senior Notes due 2034 issued in the private offering
Net proceeds Approximately $493 million After the initial purchasers’ discount and estimated fees and expenses
Coupon 6.750% Senior Notes due 2034
Maturity 2034 Senior Notes issued in the private offering
Redeemed notes coupon 4.875% Outstanding Senior Notes due 2028, all redeemed using offering proceeds
Equity-offering redemption limit Up to 40% of original aggregate principal amount May be redeemed through December 1, 2029 using proceeds from certain equity offerings
Equity-offering redemption price 106.750% of principal Applies to the specified redemption using proceeds from certain equity offerings through December 1, 2029
Change-of-control repurchase price 101% of principal Offer to repurchase may be required upon certain change-of-control events
senior unsecured obligations financial
"The Notes are the senior unsecured obligations of the Company"
Senior unsecured obligations are loans or bonds that a company promises to pay back with its own money, but without any special guarantees or collateral. If the company runs into financial trouble, these debts are paid after other debts with priority, meaning they are less protected but still important. They matter because they show how risky it is to lend money to a company.
make-whole premium financial
"plus an applicable “make-whole premium”"
A make-whole premium is an extra payment a borrower must give bondholders when repaying debt early to compensate them for lost future interest; think of it as a lump-sum “catch-up” to leave lenders financially where they would have been if the loan had run its full term. It matters to investors because it affects how much they receive on early redemption and influences a company’s decision to refinance or repay debt, altering bond value and expected returns.
sale and leaseback transactions financial
"enter into certain sale and leaseback transactions"
qualified institutional buyers regulatory
"persons reasonably believed to be “qualified institutional buyers” under Rule 144A"
Qualified institutional buyers are large organizations, like big investment firms or banks, that are allowed to buy certain types of investment opportunities not available to everyday investors. Their size and experience matter because it ensures they understand and can handle complex financial deals, making markets more efficient and secure.
Regulation S regulatory
"under Regulation S of the Securities Act"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did SAIC raise in its notes offering?

SAIC issued $500 million aggregate principal amount of 6.750% Senior Notes due 2034 and received approximately $493 million in net proceeds after the initial purchasers’ discount and estimated fees and expenses.

When can SAIC redeem its 2034 notes, and at what price?

Before December 1, 2029, SAIC may redeem notes at 100% of principal plus accrued interest and a make-whole premium. On or after that date, redemption prices set in the notes apply. Through December 1, 2029, SAIC may also redeem up to 40% of original principal at 106.750% using proceeds from certain equity offerings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001571123false00015711232026-11-132026-11-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________________
Form 8-K
_________________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 13, 2026

_________________________________________________________
Science Applications International Corporation
(Exact name of registrant as specified in its charter)
_________________________________________________________
Delaware001-3583246-1932921
(State or other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
12010 Sunset Hills Road, Reston, VA 20190
(Address of Principal Executive Offices) (Zip Code)
(703) 676-4300
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address if changed since last report) 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $.0001 per shareSAICThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 1.01. Entry into a Material Definitive Agreement.
On November 13, 2026, Science Applications International Corporation (the "Company") closed its previously announced private offering (the “Offering”) of $500 million aggregate principal amount of 6.750% Senior Notes due 2034 (the “Notes”).
The Company received net proceeds from the Offering of approximately $493 million, after deducting the initial purchasers’ discount and estimated fees and Offering expenses payable by the Company. The Company used the net proceeds from the Offering to redeem all of its outstanding 4.875% Senior Notes due 2028 (the “2028 Notes”) and intends to pay estimated fees and expenses of the Offering, with any remaining net proceeds being used for general corporate purposes.
The Notes were issued pursuant to an Indenture, dated November 13, 2026 (the “Indenture”), among the Company, the guarantors party thereto (the “Guarantors”) and Truist Bank, as trustee.
The Notes are the senior unsecured obligations of the Company and are fully and unconditionally guaranteed by each of the Company’s existing and future domestic subsidiaries that guarantee the Company’s obligations under its Third Amended and Restated Credit Agreement and certain other indebtedness, including the 5.875% Senior Notes due 2033. The Indenture limits the ability of the Company and its subsidiaries (subject to certain exceptions and qualifications) to incur liens securing indebtedness; enter into certain sale and leaseback transactions; and consolidate, merge or sell all or substantially all of the Company’s or any Guarantor’s assets.
At any time prior to December 1, 2029, the Company may redeem some or all of the Notes at a price equal to 100% of the principal amount of the Notes redeemed, plus accrued and unpaid interest, if any, to (but not including) the redemption date, plus an applicable “make-whole premium.” On or after December 1, 2029, the Company may redeem the Notes at its option, in whole at any time or in part from time to time at the redemption prices set forth in the Notes, plus accrued and unpaid interest, if any, to (but not including) the redemption date.
At any time on or prior to December 1, 2029, the Company may redeem up to 40% of the original aggregate principal amount of the Notes with the net cash proceeds of certain equity offerings at a redemption price equal to 106.750% of the principal amount of the Notes, together with accrued and unpaid interest, if any, to (but not including) the redemption date.
Upon the occurrence of certain events constituting a change of control, the Company may be required to make an offer to repurchase all of the Notes (unless otherwise redeemed) at a price equal to 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to (but not including) the date of purchase.
The Indenture contains customary events of default, which include (subject in certain cases to customary grace and cure periods) nonpayment of principal or interest; breach of other agreements in the Indenture; failure to pay certain other indebtedness; certain events of bankruptcy or insolvency; failure to pay certain final judgments and failure of certain guarantees to be enforceable.
The foregoing summary description of the Indenture and the Notes does not purport to be complete and is qualified in its entirety by reference to the terms of the Indenture and the form of Notes included therein, copies of which are filed hereto as Exhibits 4.1 and 4.2, respectively, and incorporated by reference in this Current Report on Form 8-K.
This Current Report on Form 8-K does not constitute an offer to sell, or the solicitation of an offer to buy, the Notes or any other securities of the Company.
The Notes and related guarantees were offered and sold only to persons reasonably believed to be “qualified institutional buyers” under Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”), and to certain non-U.S. persons outside the United States under Regulation S of the Securities Act. The Notes and related guarantees have not been, and will not be, registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any applicable state securities laws.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The disclosure set forth in Item 1.01 above is incorporated by reference into this Item 2.03.



Item 9.01. Financial Statements and Exhibits
(d) Exhibits.
Exhibit
Number
  Description of Exhibit
4.1
  Indenture, dated November 13, 2026, by and among Science Applications International Corporation, the guarantors party thereto and Truist Bank, as trustee.
4.2
Form of 6.750% Senior Notes due 2034 (included in Exhibit 4.1).
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
Forward-Looking Statements
Certain statements in this Current Report on Form 8-K contain or are based on forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “may,” “will,” “should,” “expects,” “projects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “outlook,” and similar words or phrases. Forward-looking statements in this release may include, among others, statements relating to the Offering and the use of net proceeds therefrom. Such statements are not guarantees of future performance and are subject to risks and uncertainties, including but not limited to regulatory and legal developments, governmental and political conditions, competitive pressures, technological advancements, economic conditions, supply chain disruptions, and the risk factors mentioned below that could cause actual results to differ materially from those expressed or implied in this release. The risk factors that could cause our actual results to differ materially from those results anticipated by our forward-looking statements include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission (the “SEC”), which may be viewed or obtained through the Investor Relations section of our website at www.saic.com or on the SEC’s website at www.sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. The Company expressly disclaims any duty to update or revise any forward-looking statements provided in this Current Report on Form 8-K to reflect subsequent events, changed circumstances or expectations, or the occurrence of unanticipated events after the date of those statements or to conform these statements to actual results.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 13, 2026
Science Applications International Corporation
 
By:/s/ Hilary L. Hageman
Hilary L. Hageman
Executive Vice President, General Counsel and Corporate Secretary


Filing Exhibits & Attachments

4 documents

Keep reading